Bioinformatics Services Market - Databook 2025 to 2034

The global bioinformatics services market size was estimated at USD 3,220 million in 2024 and is projected to be worth around USD 12,470 million by 2034, growing at a CAGR of 14.5% from 2025 to 2034.

Bioinformatics Services Market Report Highlights

• By region, North America dominated the bioinformatics services market in 2024.
• By region, Asia-Pacific is observed to be the fastest growing in the market during the forecast period.
• By type, the NGS segment dominated the bioinformatics services market in 2024.
• By type, the scientific software testing segment shows a significant growth in the market during the forecast period.
• By application, the drug discovery segment dominated the bioinformatics services market in 2024.
• By application, the proteomics segment is the fastest growing in the market during the forecast period.
• By sector, the academics segment dominated the bioinformatics services market in 2024.
• By sector, the animal segment shows a significant growth in the market during the forecast period.

Industry Valuation and Growth Rate Projection

The bioinformatics services market involves a wide range of analytical and computational services that fund investigations and analysis in the sector of bioinformatics. It is an incorporative sector that works together with biology, statistics, and computer science to determine and incorporate biological data, mainly information associated with DNA, RNA, and protein sequences. The services participated in a vital role in numerous areas of biomedical research and biology incorporating proteomics, genomics, structural biology, etc. The growing demand for bioinformatics services in various end-use industries such as forensics, consumer items, food and beverages, bioremediation, and agriculture, accompanied by the increasing research funding for bioinformatics services from the private and public sources, are driving the advancement of the bioinformatics services worldwide. Developing advanced procedures for predicting gene function and putative protein series has followed in bioinformatics services accomplishing huge demand in science.

North America is seeing a majority concentration of both revenue generation and sales in terms of the bioinformatics services market. The growing popularity of bioinformatics being deployed to conduct biological information analysis is driving significant growth in the region. The region is also home to numerous key players in the biotechnology and pharmaceuticals market, such as Johnson & Johnson and others that widely incorporate bioinformatics for clinical information analysis and the analysis of the potency of therapeutic interventions. High digitalization is a unique characteristic of the region, with several large-scale healthcare providers and health insurance brokers encouraging the use of these systems to collect data, analyze it, and utilize actionable inferences, leading to better overall patient outcomes. The United States is a mecca for research and development in pharmaceuticals and healthcare. These factors are proving instrumental in the growth of the bioinformatics services market in the region.

The market in Asia Pacific is anticipated to grow at a notable rate due to the increasing demand for bioinformatics services during the projected period. The growth of healthcare infrastructure in the region and a push towards digitization of medical records and other required healthcare documents are all expected to lead to substantial growth in the sector.

Life science institutions and healthcare need data-powered insights, with proteomics, genomics, drug advancement, and customized medicine leading huge bulk of biological information that needs expert analysis solutions. Moreover, customized medicine research is driving the need for bioinformatics services to assist them in analyzing complex biological information sets more efficiently, with governments, bodies, and private organizations investing steadily in bioinformatics to level up their information analysis abilities and encourage innovation. These global efforts are fueling demand in the bioinformatics services market.

The high cost of implementing these systems proves to be an obstacle to growth in the bioinformatics services market. Bioinformatics databases, tools, and services require substantial upfront investment. This can make them inaccessible for smaller businesses and emerging economies that may not have enough budget allocations for their effective implementation. There are also growing concerns about data security and privacy. Biomedical data is often sensitive and personal in nature, with the potential for misuse. These restrictions are leading to lower growth in the bioinformatics services market.

Artificial intelligence is transforming various sub-sectors of the medical and biotechnology industries. The implementation of these novel technologies is providing distinctive opportunities for medical advancement and treatment and care to discrete patients. AI methods, such as ML and DL algorithms, assist in the discovery and evaluation of biomarkers by efficiently determining large-scale clinical and biological datasets, analyzing complex patterns, and producing actionable information that can characterize personalized medication decisions.

The integration of AI technologies with developments in genetics, clinical research, and molecular biology is improving personalized medicine, making it more precise and well-organized. This outlook offers targeted therapies for discrete patients, mainly in analyzing and using prognostic, diagnostic, along predictive biomarkers.

Bioinformatics has enticed the attention of numerous firms and magnates and accelerated the growth of bioinformatics. The comprehension of bioinformatics is advantageous and is directly being used in biological science, including biotechnology, medical sciences, agriculture, and also environmental science. Due to research in numerous sectors of biotechnology, a huge total of biological information has been created, and bioinformatics services are used.

Bioinformatics is proceeding rapidly, possessing a huge extent in biotechnology and contributing to the future of drug advancement to discover a remedy for genetic disease and core grasp of the living system succeeding the human genome project. Bioinformatics is very cost-effective and holds a great future. Numerous firms, such as Silicon Genetics, Pubgene, IBM Life Science, and Wipro, have designed approaches for bioinformatics specialists because of the substantial expansion of the bioinformatics market.